The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jun. 18, 2002
Filed:
Jun. 20, 1994
Helen H. Lee, Lake Forest, IL (US);
Priscilla A. Swanson, Libertyville, IL (US);
Kenneth B. Idler, Trevor, WI (US);
Joseph D. Rosenblatt, Los Angeles, CA (US);
Irvin S. Y. Chen, Woodland Hills, CA (US);
David W. Golde, New York, NY (US);
Eugene Robertson, Grayslake, IL (US);
John E. Stephens, Gurnee, IL (US);
Emerson W. Chan, Libertyville, IL (US);
Mark H. Buytendorp, Cary, IL (US);
Joan E. Johnson, Libertyville, IL (US);
Cheryl T. Motley, Waukegan, IL (US);
Michelle Edwards, Kenosha, WI (US);
Cynthia Tate, Chicago, IL (US);
Bryan Peterson, Mundelein, IL (US);
Peggy Guidinger, Chicago, IL (US);
Abbott Laboratories, Abbott Park, IL (US);
Abstract
The present invention relates generally to a novel human T-cell lymphotropic, or leukemia, virus type II (HTLV-II) isolate designated NRA. HTLV-II was originally isolated from a patient with atypical hairy cell leukemia. Preliminary restriction analysis of this isolate demonstrated that it differs genetically from the prototypical HTLV-II isolate Mo. HTLV-II proviral molecular clones were obtained and the entire nucleotide sequence of the virus ascertained. The claimed invention is particularly directed toward the gp46 and p21 envelope proteins encoded by the env gene. Methods and kits for the detection of HTLV-II antibodies employing these envelope proteins are also described.